Brain Tumor Clinical Trials

The Brain Tumor Center is a leader in clinical trials, testing new and innovative approaches to improving outcomes. Here are the currently enrolling clinical trials for brain tumors:

A Phase II, Multi-center, Open-label Study of a Conditionally Replicative Adenovirus (DNX-2401) With Pembrolizumab (KEYTRUDA®) for Recurrent Glioblastoma or Gliosarcoma (CAPTIVE/KEYNOTE-192)
STING (Study of Immunotherapy in Newly Diagnosed Glioblastoma): A Phase III randomized double-blind, controlled study of ICT-107 with maintenance temozolomide (TMZ) in newly diagnosed glioblastoma following resection and concomitant TMZ chemoradiotherapy
A Single-blinded, Randomized, Controlled Study to Evaluate the Safety and Effectiveness of EVICEL® Fibrin Sealant (Human) Compared to a Hydrogel Sealant as an Adjunct to Sutured Dural Repair
A Phase 2/3 Randomized, Open-Label Study of Toca 511, a Retroviral Replicating Vector, Combined With Toca FC versus Standard of Care in Subjects Undergoing Planned Resection for Recurrent Glioblastoma or Anaplastic Astrocytoma
Cordis Enterprise Vascular Reconstruction Device and Delivery System
An Investigation of a Working Memory Training program in Brain Tumor Survivors with Cognitive Impairments
A Prospective, Multi-center Trial of NovoTTF-100A Together With Temozolomide Compared to Temozolomide Alone in Patients with Newly Diagnosed GBM
Phase I/II Trial Of Super-Selective Intraarterial Infusion Of Erbitux (Cetuximab) And Avastin (Bevacizumab) For Treatment Of Relapsed/Refractory Intracranial Glioma In Patients Under 22 Years Of Age
Convection-Enhanced Delivery of 124I-8H9 for Patients With Non-Progressive Diffuse Pontine Gliomas Previously Treated With External Beam Radiation Therapy

See a complete list of all clinical trials now enrolling at the Weill Cornell Brain and Spine Center.

Source: http://weillcornellbrainandspine.org/brain-tumor-clinical-trials

Recent Posts

Archives